Directors Dealings
Director dealings are proprietary transactions by executives, which are reportable under Art. 19 MAR. The publication of these transactions is an important contribution to the prevention of insider dealing and market manipulation. In addition, knowledge of such transactions is of great importance to the market, as these transactions provide indications of management's assessment of the company's future business prospects. The information presented here relates to companies that are under the supervision of BaFin.
Formycon AG: A reportable insider transaction was published on 29th April 2024. The reporting obligation was triggered by a person related to Closely associated.
Transaction reporting date: 29th April 2024,
The Insider Transaction was made by Mikulcik, Dr. Marc 
. The transaction toke place on 25th April 2024. The order was executed at the trading place Quotrix. . The aggregated volume was 48.000,00 EUR, based on an average price of 40,00 EUR. The nature of the Investment was Buy.
Formycon AG: A reportable insider transaction was published on 24th April 2024. The reporting obligation was triggered by a person related to Management Board.
Transaction reporting date: 24th April 2024,
The Insider Transaction was made by Glombitza, Dr. Stefan . The transaction toke place on 22nd April 2024. The order was executed at the trading place Tradegate. . The aggregated volume was 97.444,00 EUR, based on an average price of 38,98 EUR. The nature of the Investment was Buy.
Formycon AG: A reportable insider transaction was published on 31st August 2022. The reporting obligation was triggered by a person related to Management Board.
Transaction reporting date: 31st August 2022,
The Insider Transaction was made by Glombitza, Dr. Stefan . The transaction toke place on 30th August 2022. . The aggregated volume was 1.147.200,00 EUR, based on an average price of 76,48 EUR. The nature of the Investment was Sell.
Formycon AG: A reportable insider transaction was published on 5th August 2022. The reporting obligation was triggered by a person related to Management Board.
Transaction reporting date: 5th August 2022,
The Insider Transaction was made by Glombitza, Dr. Stefan . The transaction toke place on 4th August 2022. . The aggregated volume was 389.200,00 EUR, based on an average price of 19,46 EUR. The nature of the Investment was Buy.
| Type | Total | Last | Made by | Go to |
|---|---|---|---|---|
| Equity Story | 161 | 19th November 2024 | EQS Group AG | EQS |
| Corporate Research | 17 | 1st October 2024 | EQS Group AG | Corporate Research |
| Short Seller (DE) | 0 | - | - | SSR (DE) |
| Short Seller (UK) | 0 | - | - | SSR (UK) |
Disclaimer:
The combination of information with graphic elements makes an important contribution to visual orientation and navigation through complex factual topics. Essential content features can be perceived, grasped and contextually processed much faster.
The figurative marks, logos and other graphic and textual elements used on this website are for illustrative purposes only. All rights to the aforementioned elements are held by their respective owners. They are used without the intention of copyright infringement or intellectual property infringement.
If you believe that copyrights or intellectual property have been infringed by the choice of illustration, please contact us immediately to clarify the issue.